← Back to catalogue

Supartz

FDA PMA

Class III (US FDA PMA)

PMA P980044

by Seikagaku Corp.

Identity

Trade Name
SUPARTZ FX FDA PMA
Generic Name
Acid, hyaluronic, intraarticular FDA PMA

Identifiers

PMA Number
P980044 FDA PMA
FDA Product Code
MOZ FDA PMA

Classification

Device Class
Class III FDA PMA
Advisory Committee
Orthopedic FDA PMA
FDA Decision
APPR Approved FDA PMA

Supartz is a hyaluronic acid intraarticular injection indicated for the treatment of pain in osteoarthritis of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, such as acetaminophen. It is supplied as a sterile, single-use product for intraarticular administration.

The device is manufactured by Seikagaku Corp. and received FDA PMA approval (P980044) on January 24, 2001. It is intended for use in device class 3 and is indicated specifically for intraarticular use in the knee joint for osteoarthritis pain management.

Frequently asked questions

What is Supartz indicated for?

Supartz is indicated for the treatment of pain in osteoarthritis of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, such as acetaminophen, as stated in the approval documentation.

Is Supartz a single-use or reusable device?

Supartz is supplied as a sterile, single-use product for intraarticular injection, meaning it is intended for one-time use only and should not be reused.

What regulatory pathway was used for Supartz approval?

Supartz received approval through the FDA Premarket Approval (PMA) pathway, with PMA number P980044, and was granted approval on January 24, 2001.

This description and any FAQs above were generated automatically from registry data and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Active

FDA_PMA

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Seikagaku Corp.

Sources (1)

  • FDA PMA P980044 24 fields · synced Sep 18, 2026